Litcius/Paper detail

Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial

Renato D. Lópes, Pedro Gabriel Melo de Barros e Silva, Remo H.M. Furtado, Ariane Vieira Scarlatelli Macedo, Bruna Bronhara, Lucas Petri Damiani, Lilian Mazza Barbosa, Júlia de Aveiro Morata, Eduardo Ramacciotti, Priscilla de Aquino Martins, Aryadne Lyrio de Oliveira, Vinícius Santana Nunes, Luiz Eduardo Fonteles Ritt, Ana Thereza Rocha, Lucas Tramujas, Sueli Vieira dos Santos, Dario Rafael Abregu Diaz, Lorena Souza Viana, Lívia Maria Garcia Melro, Mariana Silveira de Alcântara Chaud, Estêvão Lanna Figueiredo, Fernando Carvalho Neuenschwander, Marianna Deway Andrade Dracoulakis, Rodolfo Godinho Souza Dourado Lima, Vicente Cés de Souza Dantas, Anne Cristine Silva Fernandes, Otávio Gebara, Mauro Esteves Hernandes, Diego Aparecido Rios Queiróz, Viviane Cordeiro Veiga, Manoel Fernandes Canesin, Leonardo Meira de Faria, Gilson Soares Feitosa-Filho, Marcelo Basso Gazzana, Idelzuíta Leandro Liporace, Aline de Oliveira Twardowsky, Lília Nigro Maia, Flávia Ribeiro Machado, Alexandre de Matos Soeiro, Germano Emílio Conceição‐Souza, Luciana Armaganijan, Patrícia O. Guimarães, Régis Goulart Rosa, Luciano César Pontes Azevedo, John H. Alexander, Álvaro Avezum, Alexandre Biasi Cavalcanti, Otávio Berwanger

2021The Lancet496 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Randomized controlled trial2019-20 coronavirus outbreakOpen labelD-dimerClinical trialInternal medicineVirologyOutbreakInfectious disease (medical specialty)DiseaseCOVID-19 Clinical Research StudiesHeparin-Induced Thrombocytopenia and ThrombosisRespiratory Support and Mechanisms